Skip to main content

Table 1 Analytes most significantly associated with IFNγ in COPD sputum samples

From: IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD

Analyte

Median (range)

P′-value

rs

IFNγ (pg/ml)

5.05 (18–0.45)

-

1

IL-1 receptor antagonist (ng/ml)

202 (16.7–507.3)

2.91E-18

0.72

IL-1α (pg/ml)

225 (17–2290)

1.56E-14

0.66

C-Reactive Protein (ng/ml)

0.035 (0.0132–150)

6.31E-11

0.58

sEGFR (ng/ml)

4.584 (0.385–48.064)

6.87E-11

0.58

α1-Antitrypsin (μg/ml)

11.2 (1.25–140)

1.05E-10

0.58

Haptoglobin (ng/ml)

4.26 (0.0177–62.2)

1.95E-10

0.57

Fibrinogen (ng/ml)

0.905 (0.0569–2.59)

1.98E-10

0.57

IL-1β (pg/ml)

386 (7.39–16,850)

6.57E-10

0.56

IL-18 (pg/ml)

513 (22.1–4550)

1.23E-09

0.55

α2-Macroglobulin (μg/ml)

14.5 (0.915–228)

2.31E-09

0.54

  1. The concentration of 175 analytes was determined in 105 sputum samples collected pre-, during and post-exacerbation of COPD in 24 patients using the human MAPv1.6 (Myriad RBM Inc).The top 11 analytes that had a significant correlation with IFNγ are shown in the table. Correlation was assessed by Spearman rank order correlation (rs) irrespective of whether stable, exacerbation or convalescence sample. P′-value is the significance value adjusted for multiple testing using Hochberg method to control the family wise error rate to 5%